References
- Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, Liu X. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 2012;3:1–67
- Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011;127:363–369 e1–3
- National Heart, L., and Blood Institute. Expert panel report 3: guidelines for the diagnosis and treatment of asthma. Washington DC: L. National Heart, and Blood Institute, Editor; 2007
- Halbert RJ, Tinkelman DG, Globe DR, Lin SL. Measuring asthma control is the first step to patient management: a literature review. J Asthma 2009;46:659–664
- Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE, Simons FE, et al; T.S. Group. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2009;124:895–902 e1–4
- Vollmer WM, Markson LE, O’Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med 2002;165:195–199
- Williams SA, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med 2009;51:780–785
- National Committee for Quality Assurance (NCQA). Use of appropriate medications for people with asthma. HEDIS 2014: Healthcare Effectiveness Data and Information Set. Vol. 1, narrative. Washington (DC): National Committee for Quality Assurance (NCQA); 2013
- Schatz M, Zeiger RS, Vollmer WM, Mosen D, Apter AJ, Stibolt TB, Leong A, et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 2006;117:995–1000
- Schatz M, Zeiger RS, Vollmer WM, Mosen D, Mendoza G, Apter AJ, Stibolt TB, et al. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest 2006;130:43–50
- Schatz M, Zeiger RS, Yang SJ, Chen W, Crawford WW, Sajjan SG, Allen-Ramey F. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Am J Manag Care 2010;16:327–333
- Firoozi F, Lemiere C, Beauchesne MF, Forget A, Blais L. Development and validation of database indexes of asthma severity and control. Thorax 2007;62:581–587
- Barnes P, Jonsson B, Klim J. The costs of asthma. European Respiratory Journal 1996;9:636–642
- Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003;111:1212–1218
- Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001;107:S445–S448
- Malone DC, Armstrong EP. Economic burden of asthma: implications for outcomes and cost-effectiveness analyses. Exp Rev Pharmacoecon Outcomes Res 2001;1:177–186
- Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW. Asthma: prevalence and cost of illness. Eur Respir J 2005;25:47–53
- Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Eng J Med 1992;326:862–866
- Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, Eichler HG, et al. Asthma severity and medical resource utilisation. Eur Resp J 2004;23:723–729
- Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Resp J 2001;19:61–67
- Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Resp J 1998;12:1322–1326
- Van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G, Sazonov Kocevar V. Asthma-related resource use and cost by GINA classification of severity in three European countries. Resp Med 2006;100:140–147
- Cohen JW. Sample design of the 1996 medical expenditure panel survey household component: MEPS methodology report 2. Agency for Health Care Policy and Research 1997; Rockville, MD: AHCPR publication 97-0027
- Cohen JW, Monheit AC, Beauregard KM, Cohen SB, Lefkowitz DC, Potter DE, Sommers JP, et al. The medical expenditure panel survey: a national health information resource. Inquiry 1996;33:373–389
- Medical Expenditure Panel Survey. HC-097 2005 Full year consolidated data file. Rockville: Agency for Healthcare Research and Quality Center for Financing, Access, and Cost Trends; 2007
- Tough SC, Hessel PA, Green FH, Mitchell I, Rose S, Aronson H, and Butt JC. Factors that influence emergency department visits for asthma. Can Respir J 1999;6:429–435
- Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145–152
- Wu CH, Erickson SR. The association between asthma and absenteeism among working adults in the United States: results from the 2008 medical expenditure panel survey. J Asthma 2012;49:757–764